Literature DB >> 23261848

Myasthenia gravis.

J Spillane1, E Higham, D M Kullmann.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23261848     DOI： 10.1136/bmj.e8497

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  13 in total

1.  Myasthenia gravis.

Authors:  Pierre R Bourque; Ari Breiner
Journal:  CMAJ       Date:  2018-09-24       Impact factor: 8.262

2.  Thymic carcinoma patients with myasthenia gravis exhibit better prognoses.

Authors:  Wenya Li; Zhifeng Miao; Xudong Liu; Qigang Zhang; Lei Sun; Peiwen Li; Wenke Liu; Lin Zhang
Journal:  Int J Clin Oncol       Date:  2015-07-03       Impact factor: 3.402

Review 3.  Clinical Evaluation of Blepharoptosis: Distinguishing Age-Related Ptosis from Masquerade Conditions.

Authors:  Michelle W Latting; Alison B Huggins; Douglas P Marx; Joseph N Giacometti
Journal:  Semin Plast Surg       Date:  2017-02       Impact factor: 2.314

4.  A genome-wide association study of myasthenia gravis.

Authors:  Alan E Renton; Hannah A Pliner; Carlo Provenzano; Amelia Evoli; Roberta Ricciardi; Michael A Nalls; Giuseppe Marangi; Yevgeniya Abramzon; Sampath Arepalli; Sean Chong; Dena G Hernandez; Janel O Johnson; Emanuela Bartoccioni; Flavia Scuderi; Michelangelo Maestri; J Raphael Gibbs; Edoardo Errichiello; Adriano Chiò; Gabriella Restagno; Mario Sabatelli; Mark Macek; Sonja W Scholz; Andrea Corse; Vinay Chaudhry; Michael Benatar; Richard J Barohn; April McVey; Mamatha Pasnoor; Mazen M Dimachkie; Julie Rowin; John Kissel; Miriam Freimer; Henry J Kaminski; Donald B Sanders; Bernadette Lipscomb; Janice M Massey; Manisha Chopra; James F Howard; Wilma J Koopman; Michael W Nicolle; Robert M Pascuzzi; Alan Pestronk; Charlie Wulf; Julaine Florence; Derrick Blackmore; Aimee Soloway; Zaeem Siddiqi; Srikanth Muppidi; Gil Wolfe; David Richman; Michelle M Mezei; Theresa Jiwa; Joel Oger; Daniel B Drachman; Bryan J Traynor
Journal:  JAMA Neurol       Date:  2015-04       Impact factor: 18.302

5.  Choline transporter hemizygosity results in diminished basal extracellular dopamine levels in nucleus accumbens and blunts dopamine elevations following cocaine or nicotine.

Authors:  Yu Dong; John A Dani; Randy D Blakely
Journal:  Biochem Pharmacol       Date:  2013-08-09       Impact factor: 5.858

Review 6.  When myasthenia gravis is deemed refractory: clinical signposts and treatment strategies.

Authors:  Renato Mantegazza; Carlo Antozzi
Journal:  Ther Adv Neurol Disord       Date:  2018-01-18       Impact factor: 6.570

7.  Suppression of CHRN endocytosis by carbonic anhydrase CAR3 in the pathogenesis of myasthenia gravis.

Authors:  Ailian Du; Shiqian Huang; Xiaonan Zhao; Kuan Feng; Shuangyan Zhang; Jiefang Huang; Xiang Miao; Fulvio Baggi; Rennolds S Ostrom; Yanyun Zhang; Xiangjun Chen; Congfeng Xu
Journal:  Autophagy       Date:  2017-09-29       Impact factor: 16.016

8.  Outcomes after major surgery in patients with myasthenia gravis: A nationwide matched cohort study.

Authors:  Yi-Wen Chang; Yi-Chun Chou; Chun-Chieh Yeh; Chaur-Jong Hu; Chih-Jen Hung; Chao-Shun Lin; Ta-Liang Chen; Chien-Chang Liao
Journal:  PLoS One       Date:  2017-06-30       Impact factor: 3.240

9.  MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters.

Authors:  Inga Koneczny; Judith Cossins; Patrick Waters; David Beeson; Angela Vincent
Journal:  PLoS One       Date:  2013-11-07       Impact factor: 3.240

10.  Influence of body mass index on postoperative complications after thymectomy in myasthenia gravis patients.

Authors:  Xu-Dong Liu; Ming-Rui Shao; Lei Sun; Lin Zhang; Xin-Shan Jia; Wen-Ya Li
Journal:  Oncotarget       Date:  2017-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.